LIPC
protein-codinglipase C, hepatic type, the group of Lipases
Gene summary
Enables glycerophospholipid phospholipase A1 activity and triacylglycerol lipase activity. Involved in several processes, including cholesterol homeostasis; plasma lipoprotein particle remodeling; and triglyceride catabolic process. Located in obsolete extracellular space. Implicated in several diseases, including Alzheimer's disease; coronary artery disease; familial combined hyperlipidemia; peripheral vascular disease; and type 2 diabetes mellitus. Biomarker of hyperinsulinism; obesity; and type 1 diabetes mellitus. [provided by Alliance of Genome Resources, Jun 2026]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~159.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0013533
Submitter: Laboratory for Molecular Medicine
This gene-disease relationship has undergone rapid assessment. Classifications are based on preliminary review of gene-disease validity during analysis of genomic sequencing results.
Inheritance Pattern: Unknown
Disease ID:MONDO:0013533
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0013533
Submitter: Ambry Genetics
Inheritance Pattern: SD
Disease ID:MONDO:0013533
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular
Intervention: Cardiovascular
Rationale: Surveillance and treatment for cholesterol and cardiovascular perturbations may decrease morbidity and mortality
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to LIPC variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000236.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 8 | 56 | 1 | 65 | ||
| missense | 1 | 1 | 162 | 11 | 175 | |
| nonsense | 1 | 3 | 4 | |||
| start loss | 0 | |||||
| frameshift | 7 | 7 | ||||
| splice donor/acceptor (+/-2bp) | 1 | 3 | 4 | |||
| Total | 2 | 2 | 183 | 67 | 1 | 255 |
Highest pathogenic variant AF is 0.000009292621
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000227.2 | 9 | MANE Select | |
| Ensembl | ENSP00000299022.5 | 9 | MANE Select | |
| Ensembl | ENSP00000348425.6 | 9 | Standard | |
| Ensembl | ENSP00000348425.6 | 9 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Glycerolipid metabolism - Homo sapiens (human)
- Cholesterol metabolism - Homo sapiens (human)
- Statin Pathway, Pharmacodynamics
- Familial lipoprotein lipase deficiency
- Glycerolipid Metabolism
Biological Process
- fatty acid biosynthetic process
- cholesterol metabolic process
- triglyceride catabolic process
- very-low-density lipoprotein particle remodeling
- intermediate-density lipoprotein particle remodeling
Molecular Function
- phospholipase activity
- triglyceride lipase activity
- heparin binding
- low-density lipoprotein particle binding
- apolipoprotein binding
Cellular Component
- extracellular region
- extracellular space
- endoplasmic reticulum lumen
- high-density lipoprotein particle
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000356113
- Coding exons
- 9
- Length
- 158384
- Individuals with no LoFs
- 125607
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 141
- Defined
- 125748
- p
- 0.000561
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.919 | 335 | 291 | 1.15 | 0.0000193 | 3261 |
| Missense (PolyPhen) | 121 | 105.63 | 1.1455 | 1237 | ||
| Synonymous | -1.80 | 148 | 123 | 1.21 | 0.00000939 | 969 |
| Loss of Function | 1.82 | 14 | 23.5 | 0.595 | 0.00000136 | 249 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0012 | 0.0012 | notable |
| Latino/Admixed American | 0.00035 | 0.00035 | rare |
| Ashkenazi Jewish | 0.00020 | 0.00020 | rare |
| East Asian | 0.00044 | 0.00044 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00077 | 0.00076 | rare |
| South Asian | 0.00017 | 0.00016 | rare |
| Other | 0.0013 | 0.0013 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Hepatic lipase has the capacity to catalyze hydrolysis of phospholipids, mono-, di-, and triglycerides, and acyl-CoA thioesters. It is an important enzyme in HDL metabolism. Hepatic lipase binds heparin.;
- Disease
- DISEASE: Hepatic lipase deficiency (HL deficiency) [MIM:614025]: A disorder characterized by elevated levels of beta-migrating very low density lipoproteins, and abnormally triglyceride-rich low and high density lipoproteins. {ECO:0000269|PubMed:10660332, ECO:0000269|PubMed:1301939}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.361
Intolerance Scores
- LoFtool
- 0.189
- RVIS EVS
- -0.71
- RVIS percentile EVS
- 14.78
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.457
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |